A growing crisis regarding organ transplants and an aging population has intensified the search for new and alternative therapies. With an approximate 90,000 patients on the current U.S. transplant-waiting list, a wide array of critical medical needs have gone unmet—many of which can potentially be addressed by regenerative technologies.
Regenerative medicine is a rapidly emerging branch of medicine with the overarching goal of restoring organ and/or tissue function for patients with serious injuries or chronic disease, during which the body’s own responses are insufficient.
MMI has recognized the need for current and up-to-date knowledge regarding stem cells, coupled with the need to disseminate information amongst physicians and healthcare professionals—thus creating the world's first Stem Cell Fellowship program.
New and current regenerative medical technologies can harness the power of stem cells in order to create living, functional tissues, which collectively regenerate and repair tissue and bodily organs that have been damaged due to age, disease, or congenital defects. Stem cells have the capability to access these damaged areas, restoring cells and tissues by performing a repair and renewal process, which ultimately reestablishes functionality.
In this modular training program, a group of experienced academics led by Dr. Sharon McQuillan, with extensive backgrounds in stem cell transplantation, present a series of topics that review the general principles and practices of stem cell biology, in addition to evidence-based treatments for physicians that can help optimize their patients’ health.
After completion of this modular training program, physicians will be able to choose which stem cell protocols to recommend to their patients. Sign up today, and become a pioneer in stem cell therapy and the future of regenerative medicine.
The use of stem cells is a natural progression in anti-aging and regenerative medicine. Through the use of stem cell therapy, regenerative medicine is a revolutionary approach to restore, rejuvenate, and regenerate cells, tissue, or organs that are diseased or injured. This first module of the Stem Cell Fellowship will provide a detailed foundation of the concepts of cellular biology and physiology, stem cell biology, and the intricacies of cellular signaling and cell phenotypes that are essential in regenerative medicine. All stem cell sources will be explored including fetal, placental, umbilical, cord blood, embryonic, bone marrow derived, adipose derived, peripheral blood, and induced pluripotent stem cells. Current stem cell markers, as well as the latest cell imaging devices and techniques will be discussed and demonstrated in a live, interactive setting.
Upon completion of the module, the participant will:
This module aims to improve the safe use of stem cell therapy, regenerative medicine as a revolutionary approach to restore, rejuvenate, and regenerate cells, tissue, or organs that are diseased or injured.
After completing this activity, the participant should be better able to:
This module will review disease background, statistics, etiology, current standard of care, and controversies surrounding cardiovascular and pulmonary conditions including: myocardial infarction, atherosclerosis, peripheral artery disease, deep vein thrombosis, asthma, COPD, and interstitial lung disease. And despite advances, restoring function to these damaged systems remains a formidable challenge. This module aims to educate on the recent regenerative research that suggests the adult, embryonic, cardiopoietic, and vascular stem cells may be able to replace damaged heart muscle cells and/or establish new blood vessels to supply them. This module's curriculum will analyze the various cell therapies to gain knowledge on the treatment strategies including patient selection, diagnosis, risks, and benefits.
Through the use of stem cell therapy, regenerative medicine is a revolutionary approach to restore, rejuvenate, and regenerate cells, tissue, or organs that are diseased or injured. The fourth module of the Fellowship in Stem Cell Therapies will provide a detailed foundation regarding the treatment of musculoskeletal and neurodegenerative conditions utilizing various stem cell sources. An overview of each disease condition and current standard of care will be examined. A comprehensive analysis of current research regarding these treatments will be presented as well as best practices for in-office applications will be discussed, as applicable.
Upon completion of the module, the participant will:
Through the use of stem cell therapy, regenerative medicine is a revolutionary approach to restore, rejuvenate, and regenerate cells, tissues, or organs that are diseased or injured. Module III of the Fellowship in Stem Cell Therapies provides an efficient, validated, and compliant office-based method for the isolation of autologous adult stem cells and platelet rich plasma (PRP). Autologous adult stem cell harvesting involves the removal of bone marrow or adipose tissue from the patient followed by a laboratory process that isolates the stem cells from the aspirate. Platelet rich plasma is an autologous product obtained from whole blood via density gradient centrifugation. The course curriculum consists of home study materials, plus two days of combination didactic, hands-on clinical, and laboratory experience, as well as an onsite preceptor visit.
Upon completion of this module, the participant will:
Fellowship Graduation will be held in December 2017 at our 25th Annual World Congress in Las Vegas, NV.
If you have any questions or need help with your requirements please contact the board registrar by email, email@example.com.